Insights

Herantis Pharma Plc (“Herantis), a company developing disease-modifying therapies for Parkinson’s disease, announced the signing of a grant agreement with the European Innovation Council Accelerator. The funding will launch project ReTreatPD, which will focus on preparations towards a Phase 2 clinical study with HER-096 in conjunction with Parkinson’s disease. The project includes development of biomarkers for monitoring target engagement and treatment response to HER-096 molecule. 

Funding opportunities for projects that aim to make a positive impact on our nature, environment and climate are expected to be published in mid-April, when this year’s LIFE Call for proposals is launched. Do you have what it takes to apply for the LIFE funding to boost your project? 

Research organisations focused on the multiple applications for Artificial Intelligence may not always find the right channels nor partners to commercialise their innovations. Finding the right business partners within industry may often prove as one of the obstacles to enter the markets. A project within the ELISE network is now addressing this challenge by launching a Catalogue that provides cherry-picked information on European research organisations focused on AI research, thus making it easier for academia and industry to find the right partners for a fruitful collaboration.

The European Commission has launched the ‘Sustainable and Smart Mobility Strategy’ together with an Action of 82 initiatives that lay the foundation for how the EU transport system can achieve its green and digital transformation and a 90% cut in emissions by 2050.

Making a positive impact on people’s well-being and treatment of diseases holds true for our customer projects in the health sector. We have witnessed strong growth in public funding for the health sector, and we are excited to have an opportunity to be part of various important projects that aim to tackle some of the most pressing challenges in the health sector. 

The updated EU Industrial Strategy highlights the need to accelerate the green and digital transition of the EU industry and its ecosystems. Tourism, as the most heavily hit ecosystem by the COVID-19 crisis, will be the first to have its transition pathway. The calls for project proposals are now presented. 

We talked with our customer, Professor Carin Uyl-de Groot from Erasmus University Rotterdam, on taking upon the role of Project Coordinator in the consortium project that recently secured funding from Horizon Europe. Together with nine partners, Erasmus School of Health Policy & Management, has now launched the ASCERTAIN project aiming to improve the affordability and sustainability of innovative health technologies. She reflects on the role of Project Coordinator and the successful funding application process towards Grant Agreement.

So, your company or a consortium you are in got a positive decision for the funding application in a Horizon Europe call — well done! One of the next steps in the process for the Coordinators is to get ready for the Grant Agreement. We put together some tips for you.

A new project takes productivity within agriculture and forestry to the next level. The AGRARSENSE consortium will develop European state-of-the-art technologies in electronic components and systems for future needs, building European resilience in critical sectors and strongly contribute to sustainability targets and climate change mitigation. Spinverse supported the successful funding application of AGRARSENSE Coordinator Komatsu Forest. With the three-year project starting and bringing together a consortium of 52 partners from all over Europe, Spinverse team now provides AGRARSENSE with project coordination services.

Spinverse has been coordinating the extensive CleverHealth Network (CHN) ecosystem led by Helsinki University Hospital (HUS) for a good five years now. Business Finland recently granted an extension to funding of this health care growth engine. This enables CHN to continue the work in harnessing health data, AI and Machine Learning with an aim to co-develop efficient care paths and improve patients’ daily lives. The first solutions developed in CHN projects are already progressing towards commercialisation and new joint projects are being built as we speak.